H.C. Wainwright raised the firm’s price target on Axsome Therapeutics (AXSM) to $190 from $180 and keeps a Buy rating on the shares. The firm ...

Equities researchers at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for shares of Atara ...

Transcat (NASDAQ:TRNS – Get Free Report) had its target price cut by stock analysts at HC Wainwright from $126.00 to $106.00 ...

Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Knightscope (NasdaqCM:KSCP) with a Buy ...

Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Surrozen (NasdaqCM:SRZN) with a Buy ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...

On Thursday, H.C. Wainwright reaffirmed its Buy rating and $20.00 stock price target for Aprea Therapeutics (NASDAQ:APRE), a biopharmaceutical company focused on developing and commercializing novel ...

On Wednesday, H.C. Wainwright reaffirmed a Buy rating on shares of TG Therapeutics (NASDAQ:TGTX) shares with a steady price target of $55.00. The firm's analyst highlighted the company's strong ...

H.C. Wainwright has recently initiated Gryphon Digital Mining Inc (GRYP) stock to Neutral rating, as announced on July 30, 2024, according to Finviz. Earlier, on July 23, 2021, Lake Street had ...

On Tuesday, Microbot Medical Inc (MBOT) stock saw a decline, ending the day at $1.54 which represents a decrease of $-0.24 or -13.48% from the prior close of $1.78. The stock opened at $1.82 and ...